Home » Topics » BioWorld Science

BioWorld Science
RSS

PearlRiverBio patents EGFR and HER2 mutant inhibitors

Sep. 14, 2021

USAMRIID to test Navrogen's small-molecule NK cell activators against SARS-CoV-2 infection

Sep. 14, 2021

Repurposing ritonavir as potential disease-modifying therapy for dystonia

Sep. 14, 2021

OncoPLEX yields promising results in animal models of GBM

Sep. 14, 2021

Twist Bioscience and Adicet collaborate on discovery of gamma delta T-cell cancer therapies

Sep. 14, 2021

ASCT2 is a prognostic marker in renal cell carcinoma

Sep. 14, 2021

ARN-75039 or ARN-75041 as potent arenavirus fusion inhibitors

Sep. 14, 2021

C-118P demonstrates antiproliferative activity in models of HCC

Sep. 14, 2021

ORAI1 behind the pathogenesis of pulmonary arterial hypertension

Sep. 14, 2021

Pre-existing chromosomal instability may predict response to paclitaxel

Sep. 14, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...